460 related articles for article (PubMed ID: 17845687)
1. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer in chronic atrophic gastritis. Associated gastric ulcer adds no further risk.
Testoni PA; Masci E; Marchi R; Guslandi M; Ronchi G; Tittobello A
J Clin Gastroenterol; 1987 Jun; 9(3):298-302. PubMed ID: 3611683
[TBL] [Abstract][Full Text] [Related]
3. [Gastric mucosal lesions and their transition rates in high risk population of gastric cancer].
You WC
Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):100-2. PubMed ID: 1879285
[TBL] [Abstract][Full Text] [Related]
4. Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study.
Rugge M; Baffa R; Farinati F; Di Mario F; Guido M; Valiante F; Ninfo V
Ital J Gastroenterol; 1991 Feb; 23(2):70-3. PubMed ID: 1747506
[TBL] [Abstract][Full Text] [Related]
5. [Gastroscopy in follow-up studies of patients with chronic atrophic gastritis and diagnosis of early gastric cancer].
Sokolov LK; Nikiforov PA; Vasil'ev ID; Gul'kevich KIu; Sklianskaia OA; Iarushnikov KIu
Klin Med (Mosk); 1990 Nov; 68(11):108-11. PubMed ID: 2283796
[TBL] [Abstract][Full Text] [Related]
6. [Chronic atrophic gastritis and the risk of cancer].
Gabrielli F; Nemeth A
Minerva Chir; 1990 Oct; 45(19):1205-16. PubMed ID: 2074941
[TBL] [Abstract][Full Text] [Related]
7. [Precancerous conditions in gastric cancer (II): relationship between atrophic gastritis-intestinal metaplasia-gastric dysplasia-gastric carcinoma].
Martínez Díaz FJ; Canteras Jordana M; Ortuño Pacheco G
Rev Esp Enferm Dig; 1991 Jul; 80(1):17-21. PubMed ID: 1931240
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and quantitative determinations of pepsinogen I in gastric cancer and premalignant changes of the stomach.
Westerveld BD; Pals G; Défize J; Pronk J; Frants RR; Kreuning J; Eriksson AW; Meuwissen SG
Prog Clin Biol Res; 1985; 173():201-12. PubMed ID: 3885251
[TBL] [Abstract][Full Text] [Related]
9. [Non-specific chronic gastritis and gastric dysplasia, what is their clinical values?].
Martínez Alcalá F; Rivera Hueto F; Galera Davidson H; Martínez Pérez F
Rev Esp Enferm Apar Dig; 1989 Dec; 76(6 Pt 1):545-50. PubMed ID: 2623309
[TBL] [Abstract][Full Text] [Related]
10. The relation of serum pepsinogen to gastric cancer and its precursors in Hawaii Japanese men: a progress report.
Stemmermann GN; Heilbrun LK; Nomura A; Samloff IM
Prog Clin Biol Res; 1985; 173():213-20. PubMed ID: 3983194
[TBL] [Abstract][Full Text] [Related]
11. [The dynamics of the focal changes in the gastric mucosa of patients with chronic gastritis based on the data from a multiyear endoscopic observation in a polyclinic].
Sokolov LK; Nikiforov PA; Sklianskaia OA; Vasil'ev ID; Iarushnikov KIu
Ter Arkh; 1991; 63(4):124-6. PubMed ID: 2068662
[TBL] [Abstract][Full Text] [Related]
12. Second follow-up study of mucosal changes in the gastric remnant after resection for peptic ulcer disease.
Ovaska JT; Havia TV; Pekkala ES; Ekfors TO; Kujari HP
Acta Chir Scand; 1989; 155(1):35-8. PubMed ID: 2929201
[TBL] [Abstract][Full Text] [Related]
13. Follow-up observations on chronic gastritis, intestinal metaplasia and dysplasia.
Xu CP; Liu WW
Chin Med J (Engl); 1985 May; 98(5):347-8. PubMed ID: 3926407
[No Abstract] [Full Text] [Related]
14. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Barbosa J; Guilherme M; Moreira-Dias L; Lomba-Viana H; Silva R; Abreu N; Lomba-Viana R
Neoplasia; 2004; 6(5):449-56. PubMed ID: 15548353
[TBL] [Abstract][Full Text] [Related]
15. Gastric precancerous process in a high risk population: cohort follow-up.
Correa P; Haenszel W; Cuello C; Zavala D; Fontham E; Zarama G; Tannenbaum S; Collazos T; Ruiz B
Cancer Res; 1990 Aug; 50(15):4737-40. PubMed ID: 2369748
[TBL] [Abstract][Full Text] [Related]
16. S100 protein-positive dendritic cells and the significance of their density in gastric precancerous lesions.
Huang JA; Huang HD; Peng QB; Zhu ZJ; Yu XR
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(2):93-6. PubMed ID: 2243839
[TBL] [Abstract][Full Text] [Related]
17. Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?
Farinati F; Di Mario F; Plebani M; Cielo R; Fanton MC; Valiante F; Masiero M; De Boni M; Della Libera G; Burlina A
Ital J Gastroenterol; 1991 May; 23(4):194-6. PubMed ID: 1751813
[TBL] [Abstract][Full Text] [Related]
18. [Precancerous lesions of gastric cancer (I): incidence in 2 population groups: symptomatic and asymptomatic].
Martínez Díaz FJ; Canteras Jordana M; Ortuño Pacheco G
Rev Esp Enferm Dig; 1991 Jun; 79(6):397-403. PubMed ID: 1910917
[TBL] [Abstract][Full Text] [Related]
19. [Gastric dysplasia: its incidence in precancerous conditions, advanced cancer and early cancer].
Hojman D; Cenoz MC; Even L; Puzzo MA
Acta Gastroenterol Latinoam; 1988; 18(4):231-48. PubMed ID: 3255219
[TBL] [Abstract][Full Text] [Related]
20. [Chronic gastritis and intestinal metaplasia (author's transl)].
Cornet A; Barbier JP; Carnot F; Seffar M
Ann Med Interne (Paris); 1979; 130(2):87-91. PubMed ID: 434720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
